HelloBello
Series A in 2025
HelloBello is a PetTech company specializing in freshly cooked, human-grade dog food tailored to meet the specific nutritional needs of pets. Operating primarily in German-speaking markets, HelloBello offers personalized meals that are free from by-products, ensuring high-quality nutrition for dogs. The food is prepared using natural ingredients such as millet and seaweed, minimizing the reliance on supplements and enhancing digestibility. By collaborating with a specialized veterinarian, HelloBello utilizes a proprietary algorithm to determine the precise nutritional requirements of each dog. The meals are individually portioned, packaged, and delivered directly to customers' homes, promoting convenience and quality in pet nutrition.
Greenpass
Seed Round in 2024
Greenpass is a software-as-a-service (SaaS) platform dedicated to enhancing climate resilience in urban planning and design, fostering the development of livable cities. The company specializes in managing, optimizing, and certifying both individual real estate assets and entire property portfolios to ensure they meet climate resilience standards. By integrating nature-based solutions and green infrastructures into its offerings, Greenpass addresses critical urban challenges such as climate change, urban heat islands, and microclimates. The platform not only promotes environmentally responsible practices but also aligns with environmental, social, and governance (ESG) regulations, enabling stakeholders to optimize their investments while maximizing overall environmental impact.
Kranus Health
Series A in 2022
Kranus Health is a prominent global provider of virtual care in the field of Urology, specializing in clinically validated therapies for various conditions, including Andrology and Uro-Oncology. The company operates a digital health platform designed to assist men in overcoming issues such as erectile dysfunction and nausea. Its comprehensive platform features pelvic floor training, cardiovascular training, mental training, medical supervision, and preventive therapies, allowing patients to manage their health conditions from home. By focusing on innovative solutions, Kranus Health aims to improve patients' quality of life and promote healthier, longer lives.
Greenpass
Seed Round in 2022
Greenpass is a software-as-a-service (SaaS) platform dedicated to enhancing climate resilience in urban planning and design, fostering the development of livable cities. The company specializes in managing, optimizing, and certifying both individual real estate assets and entire property portfolios to ensure they meet climate resilience standards. By integrating nature-based solutions and green infrastructures into its offerings, Greenpass addresses critical urban challenges such as climate change, urban heat islands, and microclimates. The platform not only promotes environmentally responsible practices but also aligns with environmental, social, and governance (ESG) regulations, enabling stakeholders to optimize their investments while maximizing overall environmental impact.
Contextflow
Series A in 2021
Contextflow GmbH is a Vienna-based company that specializes in developing machine learning and artificial intelligence solutions for radiology image search and analysis. Founded in 2016, Contextflow has created a 3D image-based search engine that allows radiologists to quickly identify regions of interest within medical images, specifically targeting over 18 patterns in lung CT scans. The technology enables the rapid retrieval of visually similar cases, relevant descriptions, and differential diagnoses, thereby streamlining the decision-making process for healthcare professionals. Contextflow's software enhances diagnostic workflows and integrates seamlessly into existing PACS systems, ultimately improving patient care. The company has formed strategic partnerships with notable organizations, including the Radiology Center and Boehringer Ingelheim, and has garnered recognition for its innovative approach, such as being awarded the Most Promising Startup distinction. Currently, Contextflow is testing its solutions with multiple partners and aims to expand its international presence in the near future.
HelloBello
Seed Round in 2021
HelloBello is a PetTech company specializing in freshly cooked, human-grade dog food tailored to meet the specific nutritional needs of pets. Operating primarily in German-speaking markets, HelloBello offers personalized meals that are free from by-products, ensuring high-quality nutrition for dogs. The food is prepared using natural ingredients such as millet and seaweed, minimizing the reliance on supplements and enhancing digestibility. By collaborating with a specialized veterinarian, HelloBello utilizes a proprietary algorithm to determine the precise nutritional requirements of each dog. The meals are individually portioned, packaged, and delivered directly to customers' homes, promoting convenience and quality in pet nutrition.
aidhere
Seed Round in 2021
Aidhere is a developer of digital therapeutics focused on providing long-term solutions for obesity management. The company creates mobile applications that offer holistic digital therapies centered on nutrition, behavior, and exercise. Through its programs, Aidhere enables users to access videos and exercises that facilitate sustainable health improvements. By promoting behavior change, the company's digital health applications aim to help patients lead healthier lives over the long term.
XUND is a Vienna-based healthcare technology company founded in 2018, specializing in digitizing patient interactions and transforming data into actionable insights. The company offers a Patient Interaction Suite that utilizes advanced Natural Language Processing (NLP) technology to enhance prevention, speed up diagnoses, and facilitate integrated monitoring. XUND's innovative approach allows for the automatic analysis of millions of medical publications, covering over 4,000 condition concepts to deliver high-quality medical insights. By employing artificial intelligence, the interaction suite simplifies patient-doctor communication, enabling patients to understand their symptoms and receive clear, factual feedback on their health, ultimately guiding them toward appropriate next steps for recovery. As a medical device manufacturer, XUND is committed to improving healthcare accessibility and efficiency.